Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Fibrinogen, a vascular risk factor]

J P Caen1, J Soria, J P Collet

  • 1I.V.S. Hôpital Lariboisière, Paris.

Bulletin De L'Academie Nationale De Medecine
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cognitive Functioning in Adults with Phenylketonuria in a Cohort of Spanish Patients.

Behavioural neurology·2023
Same author

Definition of minimal disease activity in psoriasis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

[Prevalence of osteoarticular infections by Enterobacteria producing extended-spectrum -lactamases].

Acta ortopedica mexicana·2020
Same author

Redefining the therapeutic objective in psoriatic patients candidates for biological therapy.

The Journal of dermatological treatment·2017
Same author

Clinical evidence of the role of the cerebellum in the suppression of overt articulatory movements during reading. A study of reading in children and adolescents treated for cerebellar pilocytic astrocytoma.

Cerebellum (London, England)·2014
Same author

Sedation with sevoflurane in postoperative cardiac surgery: influence on troponin T and creatinine values.

Heart, lung and vessels·2014
Same journal

[Advances and perspectives in vascularized composite allotransplantation preservation].

Bulletin de l'Academie nationale de medecine·2025
Same journal

[COVID-19: Neurological manifestations and complications during the acute phase of the disease].

Bulletin de l'Academie nationale de medecine·2024
Same journal

[Role of psychological factors in post-COVID-19 condition].

Bulletin de l'Academie nationale de medecine·2023
Same journal

[From the origin of Sars-CoV-2 to dangerous virology/biology].

Bulletin de l'Academie nationale de medecine·2023
Same journal

[Neurological forms of long COVID in adults: Critical approach].

Bulletin de l'Academie nationale de medecine·2023
Same journal

[Post-COVID-19 syndrome].

Bulletin de l'Academie nationale de medecine·2023
See all related articles

High plasma fibrinogen levels are linked to increased risk of heart disease and stroke. However, fibrinogen may be a marker, not the direct cause, of vascular injury, with cytokines playing a key role.

Area of Science:

  • Biochemistry
  • Cardiovascular Science
  • Molecular Biology

Context:

  • Epidemiological studies consistently link elevated plasma fibrinogen levels to increased risk of coronary heart disease (CHD) and acute ischemic stroke.
  • Proposed mechanisms include fibrinogen's role in blood viscosity, fibrin clot formation, and platelet aggregation.

Purpose:

  • To explore the complex relationship between fibrinogen levels, vascular disease pathogenesis, and potential confounding factors.
  • To investigate whether increased fibrinogen is a direct cause or a marker of underlying inflammatory processes.
  • To examine the role of structurally variant fibrinogen in atherosclerosis and thrombotic diseases.

Summary:

  • While high fibrinogen correlates with vascular disease, it may act as a marker for cytokines (e.g., interleukin-6) that induce endothelial damage and tumor necrosis factor (TNF) production.

Related Experiment Videos

  • Atherosclerosis pathogenesis may involve not only increased fibrinogen concentration but also structurally variant fibrinogen.
  • Dysfibrinogenemia, characterized by abnormal fibrin clot structure, is associated with increased thrombotic risk, potentially due to reduced fibrinolysis or altered thrombin binding.

    • Impact:

    • Clarifies that elevated fibrinogen may not be the direct causative agent of vascular disease but rather an indicator of cytokine-driven inflammation.
    • Highlights the significance of structurally abnormal fibrinogen variants in the development of atherosclerosis and thrombotic events.
    • Suggests novel diagnostic or therapeutic targets by differentiating between fibrinogen as a marker versus a direct contributor to vascular pathology.